nodes	percent_of_prediction	percent_of_DWPC	metapath
Naproxen—AKR1C3—obesity	0.336	0.751	CbGaD
Naproxen—PTGS2—obesity	0.0589	0.132	CbGaD
Naproxen—ALB—obesity	0.0525	0.117	CbGaD
Naproxen—SLC22A6—Cimetidine—obesity	0.0384	0.139	CbGbCtD
Naproxen—CYP2C8—Bupropion—obesity	0.0344	0.125	CbGbCtD
Naproxen—CYP1A2—Phentermine—obesity	0.0313	0.114	CbGbCtD
Naproxen—CYP1A2—Phenylpropanolamine—obesity	0.0299	0.109	CbGbCtD
Naproxen—CYP2C9—Phentermine—obesity	0.0282	0.103	CbGbCtD
Naproxen—CYP1A2—Bupropion—obesity	0.0266	0.0968	CbGbCtD
Naproxen—CYP2C8—Cimetidine—obesity	0.0253	0.0917	CbGbCtD
Naproxen—CYP2C9—Bupropion—obesity	0.024	0.0872	CbGbCtD
Naproxen—CYP1A2—Cimetidine—obesity	0.0196	0.071	CbGbCtD
Naproxen—CYP2C9—Cimetidine—obesity	0.0176	0.064	CbGbCtD
Naproxen—PTGS2—ovarian follicle—obesity	0.00265	0.126	CbGeAlD
Naproxen—AKR1C3—islet of Langerhans—obesity	0.00109	0.0521	CbGeAlD
Naproxen—ALB—gall bladder—obesity	0.00104	0.0493	CbGeAlD
Naproxen—AKR1C3—adrenal cortex—obesity	0.000867	0.0413	CbGeAlD
Naproxen—Ibuprofen—FABP2—obesity	0.000826	0.207	CrCbGaD
Naproxen—UGT2B7—digestive system—obesity	0.000712	0.0339	CbGeAlD
Naproxen—AKR1C3—pituitary gland—obesity	0.000701	0.0333	CbGeAlD
Naproxen—AKR1C3—adipose tissue—obesity	0.000698	0.0332	CbGeAlD
Naproxen—AKR1C3—adrenal gland—obesity	0.000626	0.0298	CbGeAlD
Naproxen—UGT1A1—digestive system—obesity	0.000606	0.0288	CbGeAlD
Naproxen—UGT2B7—endocrine gland—obesity	0.000589	0.028	CbGeAlD
Naproxen—PTGS2—gall bladder—obesity	0.000564	0.0269	CbGeAlD
Naproxen—Indomethacin—CES1—obesity	0.000551	0.138	CrCbGaD
Naproxen—UGT2B7—liver—obesity	0.000531	0.0253	CbGeAlD
Naproxen—UGT1A1—endocrine gland—obesity	0.0005	0.0238	CbGeAlD
Naproxen—AKR1C3—liver—obesity	0.000489	0.0233	CbGeAlD
Naproxen—UGT1A1—liver—obesity	0.000451	0.0215	CbGeAlD
Naproxen—CYP1A2—respiratory system—obesity	0.000422	0.0201	CbGeAlD
Naproxen—SLCO1A2—digestive system—obesity	0.00041	0.0195	CbGeAlD
Naproxen—Indomethacin—AKR1C3—obesity	0.000393	0.0985	CrCbGaD
Naproxen—ALB—adrenal gland—obesity	0.000389	0.0185	CbGeAlD
Naproxen—PTGS2—islet of Langerhans—obesity	0.00037	0.0176	CbGeAlD
Naproxen—PTGS1—respiratory system—obesity	0.000366	0.0174	CbGeAlD
Naproxen—PTGS2—respiratory system—obesity	0.000349	0.0166	CbGeAlD
Naproxen—Indomethacin—PPARA—obesity	0.00034	0.0854	CrCbGaD
Naproxen—SLCO1A2—endocrine gland—obesity	0.000339	0.0161	CbGeAlD
Naproxen—CYP2C9—cardiovascular system—obesity	0.000307	0.0146	CbGeAlD
Naproxen—CYP2C8—pituitary gland—obesity	0.000306	0.0145	CbGeAlD
Naproxen—SLCO1A2—liver—obesity	0.000306	0.0145	CbGeAlD
Naproxen—ALB—liver—obesity	0.000304	0.0145	CbGeAlD
Naproxen—PTGS2—adrenal cortex—obesity	0.000293	0.014	CbGeAlD
Naproxen—PTGS1—cardiovascular system—obesity	0.00028	0.0133	CbGeAlD
Naproxen—CYP1A2—digestive system—obesity	0.000268	0.0128	CbGeAlD
Naproxen—PTGS2—cardiovascular system—obesity	0.000268	0.0127	CbGeAlD
Naproxen—Agomelatine—HTR2C—obesity	0.000255	0.064	CrCbGaD
Naproxen—CYP2C9—digestive system—obesity	0.000255	0.0121	CbGeAlD
Naproxen—PTGS1—pituitary gland—obesity	0.000248	0.0118	CbGeAlD
Naproxen—PTGS1—adipose tissue—obesity	0.000247	0.0118	CbGeAlD
Naproxen—PTGS2—pituitary gland—obesity	0.000237	0.0113	CbGeAlD
Naproxen—CYP2C8—endocrine gland—obesity	0.000237	0.0113	CbGeAlD
Naproxen—PTGS2—adipose tissue—obesity	0.000236	0.0112	CbGeAlD
Naproxen—PTGS1—digestive system—obesity	0.000232	0.0111	CbGeAlD
Naproxen—Ibuprofen—BCL2—obesity	0.000232	0.0581	CrCbGaD
Naproxen—PTGS2—digestive system—obesity	0.000222	0.0106	CbGeAlD
Naproxen—CYP1A2—endocrine gland—obesity	0.000222	0.0105	CbGeAlD
Naproxen—PTGS1—adrenal gland—obesity	0.000221	0.0105	CbGeAlD
Naproxen—CYP2C8—liver—obesity	0.000213	0.0102	CbGeAlD
Naproxen—PTGS2—adrenal gland—obesity	0.000212	0.0101	CbGeAlD
Naproxen—CYP2C9—endocrine gland—obesity	0.00021	0.01	CbGeAlD
Naproxen—CYP1A2—liver—obesity	0.0002	0.00951	CbGeAlD
Naproxen—PTGS1—endocrine gland—obesity	0.000192	0.00914	CbGeAlD
Naproxen—CYP2C9—liver—obesity	0.00019	0.00903	CbGeAlD
Naproxen—Nabumetone—PTGS2—obesity	0.000184	0.0461	CrCbGaD
Naproxen—PTGS2—endocrine gland—obesity	0.000184	0.00874	CbGeAlD
Naproxen—Carprofen—PTGS2—obesity	0.000175	0.044	CrCbGaD
Naproxen—PTGS2—liver—obesity	0.000165	0.00788	CbGeAlD
Naproxen—Indomethacin—PPARG—obesity	0.000163	0.0409	CrCbGaD
Naproxen—Ibuprofen—PPARG—obesity	0.000128	0.0322	CrCbGaD
Naproxen—Suprofen—PTGS2—obesity	0.000108	0.0272	CrCbGaD
Naproxen—Tension—Bupropion—obesity	9.53e-05	0.000589	CcSEcCtD
Naproxen—Liver function test abnormal—Topiramate—obesity	9.48e-05	0.000586	CcSEcCtD
Naproxen—Arthralgia—Sibutramine—obesity	9.48e-05	0.000586	CcSEcCtD
Naproxen—Chest pain—Sibutramine—obesity	9.48e-05	0.000586	CcSEcCtD
Naproxen—Myalgia—Sibutramine—obesity	9.48e-05	0.000586	CcSEcCtD
Naproxen—Anxiety—Sibutramine—obesity	9.45e-05	0.000584	CcSEcCtD
Naproxen—Nervousness—Bupropion—obesity	9.43e-05	0.000583	CcSEcCtD
Naproxen—Oedema—Orlistat—obesity	9.39e-05	0.000581	CcSEcCtD
Naproxen—Anaphylactic shock—Orlistat—obesity	9.39e-05	0.000581	CcSEcCtD
Naproxen—Abdominal pain upper—Topiramate—obesity	9.38e-05	0.00058	CcSEcCtD
Naproxen—Discomfort—Sibutramine—obesity	9.37e-05	0.000579	CcSEcCtD
Naproxen—Hypokalaemia—Topiramate—obesity	9.35e-05	0.000578	CcSEcCtD
Naproxen—Muscle spasms—Bupropion—obesity	9.33e-05	0.000577	CcSEcCtD
Naproxen—Infection—Orlistat—obesity	9.33e-05	0.000577	CcSEcCtD
Naproxen—Fenoprofen—PTGS2—obesity	9.33e-05	0.0234	CrCbGaD
Naproxen—Breast disorder—Topiramate—obesity	9.28e-05	0.000574	CcSEcCtD
Naproxen—Dry mouth—Sibutramine—obesity	9.27e-05	0.000573	CcSEcCtD
Naproxen—Toxic epidermal necrolysis—Topiramate—obesity	9.25e-05	0.000572	CcSEcCtD
Naproxen—Nervous system disorder—Orlistat—obesity	9.21e-05	0.000569	CcSEcCtD
Naproxen—Confusional state—Sibutramine—obesity	9.16e-05	0.000567	CcSEcCtD
Naproxen—Vision blurred—Bupropion—obesity	9.15e-05	0.000566	CcSEcCtD
Naproxen—Skin disorder—Orlistat—obesity	9.12e-05	0.000564	CcSEcCtD
Naproxen—Tremor—Bupropion—obesity	9.09e-05	0.000562	CcSEcCtD
Naproxen—Gastritis—Topiramate—obesity	9.09e-05	0.000562	CcSEcCtD
Naproxen—Oedema—Sibutramine—obesity	9.09e-05	0.000562	CcSEcCtD
Naproxen—Anaphylactic shock—Sibutramine—obesity	9.09e-05	0.000562	CcSEcCtD
Naproxen—Hyperhidrosis—Orlistat—obesity	9.08e-05	0.000561	CcSEcCtD
Naproxen—Muscular weakness—Topiramate—obesity	9.06e-05	0.00056	CcSEcCtD
Naproxen—Infection—Sibutramine—obesity	9.03e-05	0.000558	CcSEcCtD
Naproxen—Ill-defined disorder—Bupropion—obesity	9.01e-05	0.000557	CcSEcCtD
Naproxen—Anaemia—Bupropion—obesity	8.97e-05	0.000555	CcSEcCtD
Naproxen—Shock—Sibutramine—obesity	8.94e-05	0.000553	CcSEcCtD
Naproxen—Abdominal distension—Topiramate—obesity	8.94e-05	0.000553	CcSEcCtD
Naproxen—Thrombocytopenia—Sibutramine—obesity	8.9e-05	0.00055	CcSEcCtD
Naproxen—Asthma—Topiramate—obesity	8.88e-05	0.000549	CcSEcCtD
Naproxen—Dysphagia—Topiramate—obesity	8.88e-05	0.000549	CcSEcCtD
Naproxen—Angioedema—Bupropion—obesity	8.87e-05	0.000548	CcSEcCtD
Naproxen—Tachycardia—Sibutramine—obesity	8.87e-05	0.000548	CcSEcCtD
Naproxen—Skin disorder—Sibutramine—obesity	8.83e-05	0.000546	CcSEcCtD
Naproxen—Eosinophilia—Topiramate—obesity	8.79e-05	0.000543	CcSEcCtD
Naproxen—Hyperhidrosis—Sibutramine—obesity	8.78e-05	0.000543	CcSEcCtD
Naproxen—Malaise—Bupropion—obesity	8.75e-05	0.000541	CcSEcCtD
Naproxen—Vertigo—Bupropion—obesity	8.72e-05	0.000539	CcSEcCtD
Naproxen—Syncope—Bupropion—obesity	8.7e-05	0.000538	CcSEcCtD
Naproxen—Pancreatitis—Topiramate—obesity	8.7e-05	0.000538	CcSEcCtD
Naproxen—Leukopenia—Bupropion—obesity	8.69e-05	0.000537	CcSEcCtD
Naproxen—Anorexia—Sibutramine—obesity	8.66e-05	0.000536	CcSEcCtD
Naproxen—Angina pectoris—Topiramate—obesity	8.65e-05	0.000535	CcSEcCtD
Naproxen—Palpitations—Bupropion—obesity	8.58e-05	0.00053	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Orlistat—obesity	8.55e-05	0.000529	CcSEcCtD
Naproxen—Bronchitis—Topiramate—obesity	8.54e-05	0.000528	CcSEcCtD
Naproxen—Loss of consciousness—Bupropion—obesity	8.53e-05	0.000528	CcSEcCtD
Naproxen—Abdominal discomfort—Topiramate—obesity	8.51e-05	0.000526	CcSEcCtD
Naproxen—Insomnia—Orlistat—obesity	8.49e-05	0.000525	CcSEcCtD
Naproxen—Hypotension—Sibutramine—obesity	8.49e-05	0.000525	CcSEcCtD
Naproxen—Cough—Bupropion—obesity	8.47e-05	0.000524	CcSEcCtD
Naproxen—Paraesthesia—Orlistat—obesity	8.43e-05	0.000521	CcSEcCtD
Naproxen—Pancytopenia—Topiramate—obesity	8.43e-05	0.000521	CcSEcCtD
Naproxen—Convulsion—Bupropion—obesity	8.41e-05	0.00052	CcSEcCtD
Naproxen—Hypertension—Bupropion—obesity	8.38e-05	0.000518	CcSEcCtD
Naproxen—Fenoprofen—ALB—obesity	8.31e-05	0.0209	CrCbGaD
Naproxen—Dysuria—Topiramate—obesity	8.3e-05	0.000513	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Sibutramine—obesity	8.28e-05	0.000512	CcSEcCtD
Naproxen—Dyspepsia—Orlistat—obesity	8.27e-05	0.000511	CcSEcCtD
Naproxen—Chest pain—Bupropion—obesity	8.26e-05	0.000511	CcSEcCtD
Naproxen—Myalgia—Bupropion—obesity	8.26e-05	0.000511	CcSEcCtD
Naproxen—Arthralgia—Bupropion—obesity	8.26e-05	0.000511	CcSEcCtD
Naproxen—Anxiety—Bupropion—obesity	8.24e-05	0.000509	CcSEcCtD
Naproxen—Insomnia—Sibutramine—obesity	8.22e-05	0.000508	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	8.21e-05	0.000508	CcSEcCtD
Naproxen—Pollakiuria—Topiramate—obesity	8.2e-05	0.000507	CcSEcCtD
Naproxen—Discomfort—Bupropion—obesity	8.16e-05	0.000505	CcSEcCtD
Naproxen—Decreased appetite—Orlistat—obesity	8.16e-05	0.000505	CcSEcCtD
Naproxen—Paraesthesia—Sibutramine—obesity	8.16e-05	0.000505	CcSEcCtD
Naproxen—Gastrointestinal disorder—Orlistat—obesity	8.11e-05	0.000501	CcSEcCtD
Naproxen—Dyspnoea—Sibutramine—obesity	8.1e-05	0.000501	CcSEcCtD
Naproxen—Photosensitivity reaction—Topiramate—obesity	8.1e-05	0.000501	CcSEcCtD
Naproxen—Fatigue—Orlistat—obesity	8.1e-05	0.000501	CcSEcCtD
Naproxen—Dry mouth—Bupropion—obesity	8.08e-05	0.0005	CcSEcCtD
Naproxen—Somnolence—Sibutramine—obesity	8.08e-05	0.0005	CcSEcCtD
Naproxen—Weight decreased—Topiramate—obesity	8.03e-05	0.000497	CcSEcCtD
Naproxen—Pain—Orlistat—obesity	8.03e-05	0.000497	CcSEcCtD
Naproxen—Hyperglycaemia—Topiramate—obesity	8.01e-05	0.000495	CcSEcCtD
Naproxen—Dyspepsia—Sibutramine—obesity	8e-05	0.000495	CcSEcCtD
Naproxen—Confusional state—Bupropion—obesity	7.99e-05	0.000494	CcSEcCtD
Naproxen—Pneumonia—Topiramate—obesity	7.96e-05	0.000492	CcSEcCtD
Naproxen—Oedema—Bupropion—obesity	7.92e-05	0.00049	CcSEcCtD
Naproxen—Anaphylactic shock—Bupropion—obesity	7.92e-05	0.00049	CcSEcCtD
Naproxen—Decreased appetite—Sibutramine—obesity	7.9e-05	0.000488	CcSEcCtD
Naproxen—Depression—Topiramate—obesity	7.89e-05	0.000488	CcSEcCtD
Naproxen—Infection—Bupropion—obesity	7.87e-05	0.000487	CcSEcCtD
Naproxen—Stevens-Johnson syndrome—Topiramate—obesity	7.85e-05	0.000485	CcSEcCtD
Naproxen—Gastrointestinal disorder—Sibutramine—obesity	7.85e-05	0.000485	CcSEcCtD
Naproxen—Shock—Bupropion—obesity	7.79e-05	0.000482	CcSEcCtD
Naproxen—Renal failure—Topiramate—obesity	7.78e-05	0.000481	CcSEcCtD
Naproxen—Constipation—Sibutramine—obesity	7.77e-05	0.000481	CcSEcCtD
Naproxen—Pain—Sibutramine—obesity	7.77e-05	0.000481	CcSEcCtD
Naproxen—Nervous system disorder—Bupropion—obesity	7.77e-05	0.00048	CcSEcCtD
Naproxen—Neuropathy peripheral—Topiramate—obesity	7.76e-05	0.00048	CcSEcCtD
Naproxen—Thrombocytopenia—Bupropion—obesity	7.76e-05	0.00048	CcSEcCtD
Naproxen—Feeling abnormal—Orlistat—obesity	7.74e-05	0.000478	CcSEcCtD
Naproxen—Tachycardia—Bupropion—obesity	7.73e-05	0.000478	CcSEcCtD
Naproxen—Stomatitis—Topiramate—obesity	7.71e-05	0.000477	CcSEcCtD
Naproxen—Skin disorder—Bupropion—obesity	7.69e-05	0.000476	CcSEcCtD
Naproxen—Urinary tract infection—Topiramate—obesity	7.69e-05	0.000476	CcSEcCtD
Naproxen—Conjunctivitis—Topiramate—obesity	7.69e-05	0.000476	CcSEcCtD
Naproxen—Gastrointestinal pain—Orlistat—obesity	7.68e-05	0.000475	CcSEcCtD
Naproxen—Hyperhidrosis—Bupropion—obesity	7.66e-05	0.000474	CcSEcCtD
Naproxen—Anorexia—Bupropion—obesity	7.55e-05	0.000467	CcSEcCtD
Naproxen—Haematuria—Topiramate—obesity	7.55e-05	0.000467	CcSEcCtD
Naproxen—Feeling abnormal—Sibutramine—obesity	7.49e-05	0.000463	CcSEcCtD
Naproxen—Epistaxis—Topiramate—obesity	7.46e-05	0.000462	CcSEcCtD
Naproxen—Urticaria—Orlistat—obesity	7.46e-05	0.000461	CcSEcCtD
Naproxen—Gastrointestinal pain—Sibutramine—obesity	7.43e-05	0.00046	CcSEcCtD
Naproxen—Sinusitis—Topiramate—obesity	7.42e-05	0.000459	CcSEcCtD
Naproxen—Abdominal pain—Orlistat—obesity	7.42e-05	0.000459	CcSEcCtD
Naproxen—Body temperature increased—Orlistat—obesity	7.42e-05	0.000459	CcSEcCtD
Naproxen—Hypotension—Bupropion—obesity	7.4e-05	0.000458	CcSEcCtD
Naproxen—Agranulocytosis—Topiramate—obesity	7.39e-05	0.000457	CcSEcCtD
Naproxen—Urticaria—Sibutramine—obesity	7.22e-05	0.000446	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Bupropion—obesity	7.22e-05	0.000446	CcSEcCtD
Naproxen—Body temperature increased—Sibutramine—obesity	7.18e-05	0.000444	CcSEcCtD
Naproxen—Abdominal pain—Sibutramine—obesity	7.18e-05	0.000444	CcSEcCtD
Naproxen—Insomnia—Bupropion—obesity	7.17e-05	0.000443	CcSEcCtD
Naproxen—Haemoglobin—Topiramate—obesity	7.14e-05	0.000442	CcSEcCtD
Naproxen—Rhinitis—Topiramate—obesity	7.12e-05	0.00044	CcSEcCtD
Naproxen—Paraesthesia—Bupropion—obesity	7.11e-05	0.00044	CcSEcCtD
Naproxen—Haemorrhage—Topiramate—obesity	7.1e-05	0.000439	CcSEcCtD
Naproxen—Hepatitis—Topiramate—obesity	7.1e-05	0.000439	CcSEcCtD
Naproxen—Hallucination—Topiramate—obesity	7.07e-05	0.000437	CcSEcCtD
Naproxen—Dyspnoea—Bupropion—obesity	7.06e-05	0.000437	CcSEcCtD
Naproxen—Pharyngitis—Topiramate—obesity	7.05e-05	0.000436	CcSEcCtD
Naproxen—Somnolence—Bupropion—obesity	7.04e-05	0.000436	CcSEcCtD
Naproxen—Urinary tract disorder—Topiramate—obesity	7.02e-05	0.000434	CcSEcCtD
Naproxen—Oedema peripheral—Topiramate—obesity	7e-05	0.000433	CcSEcCtD
Naproxen—Connective tissue disorder—Topiramate—obesity	6.98e-05	0.000432	CcSEcCtD
Naproxen—Dyspepsia—Bupropion—obesity	6.97e-05	0.000431	CcSEcCtD
Naproxen—Urethral disorder—Topiramate—obesity	6.96e-05	0.000431	CcSEcCtD
Naproxen—Hypersensitivity—Orlistat—obesity	6.92e-05	0.000428	CcSEcCtD
Naproxen—Decreased appetite—Bupropion—obesity	6.89e-05	0.000426	CcSEcCtD
Naproxen—Indomethacin—PTGS2—obesity	6.88e-05	0.0173	CrCbGaD
Naproxen—Visual impairment—Topiramate—obesity	6.85e-05	0.000423	CcSEcCtD
Naproxen—Gastrointestinal disorder—Bupropion—obesity	6.84e-05	0.000423	CcSEcCtD
Naproxen—Fatigue—Bupropion—obesity	6.83e-05	0.000422	CcSEcCtD
Naproxen—Pain—Bupropion—obesity	6.77e-05	0.000419	CcSEcCtD
Naproxen—Constipation—Bupropion—obesity	6.77e-05	0.000419	CcSEcCtD
Naproxen—Asthenia—Orlistat—obesity	6.74e-05	0.000417	CcSEcCtD
Naproxen—Erythema multiforme—Topiramate—obesity	6.72e-05	0.000415	CcSEcCtD
Naproxen—Hypersensitivity—Sibutramine—obesity	6.7e-05	0.000414	CcSEcCtD
Naproxen—Pruritus—Orlistat—obesity	6.64e-05	0.000411	CcSEcCtD
Naproxen—Eye disorder—Topiramate—obesity	6.64e-05	0.000411	CcSEcCtD
Naproxen—Tinnitus—Topiramate—obesity	6.62e-05	0.00041	CcSEcCtD
Naproxen—Cardiac disorder—Topiramate—obesity	6.59e-05	0.000408	CcSEcCtD
Naproxen—Feeling abnormal—Bupropion—obesity	6.53e-05	0.000404	CcSEcCtD
Naproxen—Asthenia—Sibutramine—obesity	6.52e-05	0.000403	CcSEcCtD
Naproxen—Gastrointestinal pain—Bupropion—obesity	6.48e-05	0.000401	CcSEcCtD
Naproxen—Angiopathy—Topiramate—obesity	6.45e-05	0.000399	CcSEcCtD
Naproxen—Pruritus—Sibutramine—obesity	6.43e-05	0.000398	CcSEcCtD
Naproxen—Diarrhoea—Orlistat—obesity	6.42e-05	0.000397	CcSEcCtD
Naproxen—Immune system disorder—Topiramate—obesity	6.42e-05	0.000397	CcSEcCtD
Naproxen—Mediastinal disorder—Topiramate—obesity	6.4e-05	0.000396	CcSEcCtD
Naproxen—Chills—Topiramate—obesity	6.37e-05	0.000394	CcSEcCtD
Naproxen—Urticaria—Bupropion—obesity	6.29e-05	0.000389	CcSEcCtD
Naproxen—Alopecia—Topiramate—obesity	6.28e-05	0.000388	CcSEcCtD
Naproxen—Body temperature increased—Bupropion—obesity	6.26e-05	0.000387	CcSEcCtD
Naproxen—Abdominal pain—Bupropion—obesity	6.26e-05	0.000387	CcSEcCtD
Naproxen—Mental disorder—Topiramate—obesity	6.22e-05	0.000385	CcSEcCtD
Naproxen—Diarrhoea—Sibutramine—obesity	6.22e-05	0.000384	CcSEcCtD
Naproxen—Dizziness—Orlistat—obesity	6.21e-05	0.000384	CcSEcCtD
Naproxen—Erythema—Topiramate—obesity	6.18e-05	0.000382	CcSEcCtD
Naproxen—Malnutrition—Topiramate—obesity	6.18e-05	0.000382	CcSEcCtD
Naproxen—Indomethacin—ALB—obesity	6.13e-05	0.0154	CrCbGaD
Naproxen—Flatulence—Topiramate—obesity	6.09e-05	0.000377	CcSEcCtD
Naproxen—Flurbiprofen—PTGS2—obesity	6.09e-05	0.0153	CrCbGaD
Naproxen—Tension—Topiramate—obesity	6.07e-05	0.000375	CcSEcCtD
Naproxen—Dizziness—Sibutramine—obesity	6.01e-05	0.000372	CcSEcCtD
Naproxen—Nervousness—Topiramate—obesity	6.01e-05	0.000371	CcSEcCtD
Naproxen—Vomiting—Orlistat—obesity	5.97e-05	0.000369	CcSEcCtD
Naproxen—Muscle spasms—Topiramate—obesity	5.95e-05	0.000368	CcSEcCtD
Naproxen—Rash—Orlistat—obesity	5.92e-05	0.000366	CcSEcCtD
Naproxen—Dermatitis—Orlistat—obesity	5.91e-05	0.000366	CcSEcCtD
Naproxen—Headache—Orlistat—obesity	5.88e-05	0.000364	CcSEcCtD
Naproxen—Hypersensitivity—Bupropion—obesity	5.84e-05	0.000361	CcSEcCtD
Naproxen—Vision blurred—Topiramate—obesity	5.83e-05	0.00036	CcSEcCtD
Naproxen—Tremor—Topiramate—obesity	5.79e-05	0.000358	CcSEcCtD
Naproxen—Vomiting—Sibutramine—obesity	5.78e-05	0.000357	CcSEcCtD
Naproxen—Ill-defined disorder—Topiramate—obesity	5.74e-05	0.000355	CcSEcCtD
Naproxen—Rash—Sibutramine—obesity	5.73e-05	0.000354	CcSEcCtD
Naproxen—Dermatitis—Sibutramine—obesity	5.72e-05	0.000354	CcSEcCtD
Naproxen—Anaemia—Topiramate—obesity	5.72e-05	0.000353	CcSEcCtD
Naproxen—Headache—Sibutramine—obesity	5.69e-05	0.000352	CcSEcCtD
Naproxen—Asthenia—Bupropion—obesity	5.68e-05	0.000351	CcSEcCtD
Naproxen—Pruritus—Bupropion—obesity	5.6e-05	0.000347	CcSEcCtD
Naproxen—Nausea—Orlistat—obesity	5.58e-05	0.000345	CcSEcCtD
Naproxen—Malaise—Topiramate—obesity	5.58e-05	0.000345	CcSEcCtD
Naproxen—Vertigo—Topiramate—obesity	5.56e-05	0.000344	CcSEcCtD
Naproxen—Syncope—Topiramate—obesity	5.55e-05	0.000343	CcSEcCtD
Naproxen—Leukopenia—Topiramate—obesity	5.54e-05	0.000342	CcSEcCtD
Naproxen—Ketoprofen—PTGS2—obesity	5.51e-05	0.0138	CrCbGaD
Naproxen—Palpitations—Topiramate—obesity	5.47e-05	0.000338	CcSEcCtD
Naproxen—Loss of consciousness—Topiramate—obesity	5.44e-05	0.000336	CcSEcCtD
Naproxen—Flurbiprofen—ALB—obesity	5.42e-05	0.0136	CrCbGaD
Naproxen—Diarrhoea—Bupropion—obesity	5.42e-05	0.000335	CcSEcCtD
Naproxen—Ibuprofen—PTGS2—obesity	5.42e-05	0.0136	CrCbGaD
Naproxen—Nausea—Sibutramine—obesity	5.4e-05	0.000334	CcSEcCtD
Naproxen—Cough—Topiramate—obesity	5.4e-05	0.000334	CcSEcCtD
Naproxen—Convulsion—Topiramate—obesity	5.36e-05	0.000331	CcSEcCtD
Naproxen—Hypertension—Topiramate—obesity	5.34e-05	0.00033	CcSEcCtD
Naproxen—Chest pain—Topiramate—obesity	5.27e-05	0.000326	CcSEcCtD
Naproxen—Arthralgia—Topiramate—obesity	5.27e-05	0.000326	CcSEcCtD
Naproxen—Myalgia—Topiramate—obesity	5.27e-05	0.000326	CcSEcCtD
Naproxen—Anxiety—Topiramate—obesity	5.25e-05	0.000324	CcSEcCtD
Naproxen—Dizziness—Bupropion—obesity	5.24e-05	0.000324	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	5.23e-05	0.000323	CcSEcCtD
Naproxen—Discomfort—Topiramate—obesity	5.2e-05	0.000322	CcSEcCtD
Naproxen—Dry mouth—Topiramate—obesity	5.15e-05	0.000318	CcSEcCtD
Naproxen—Confusional state—Topiramate—obesity	5.09e-05	0.000315	CcSEcCtD
Naproxen—Oedema—Topiramate—obesity	5.05e-05	0.000312	CcSEcCtD
Naproxen—Vomiting—Bupropion—obesity	5.04e-05	0.000311	CcSEcCtD
Naproxen—Infection—Topiramate—obesity	5.01e-05	0.00031	CcSEcCtD
Naproxen—Rash—Bupropion—obesity	5e-05	0.000309	CcSEcCtD
Naproxen—Dermatitis—Bupropion—obesity	4.99e-05	0.000309	CcSEcCtD
Naproxen—Shock—Topiramate—obesity	4.97e-05	0.000307	CcSEcCtD
Naproxen—Headache—Bupropion—obesity	4.96e-05	0.000307	CcSEcCtD
Naproxen—Nervous system disorder—Topiramate—obesity	4.95e-05	0.000306	CcSEcCtD
Naproxen—Thrombocytopenia—Topiramate—obesity	4.94e-05	0.000306	CcSEcCtD
Naproxen—Tachycardia—Topiramate—obesity	4.93e-05	0.000305	CcSEcCtD
Naproxen—Ketoprofen—ALB—obesity	4.91e-05	0.0123	CrCbGaD
Naproxen—Skin disorder—Topiramate—obesity	4.9e-05	0.000303	CcSEcCtD
Naproxen—Hyperhidrosis—Topiramate—obesity	4.88e-05	0.000302	CcSEcCtD
Naproxen—Ibuprofen—ALB—obesity	4.83e-05	0.0121	CrCbGaD
Naproxen—Anorexia—Topiramate—obesity	4.81e-05	0.000298	CcSEcCtD
Naproxen—Hypotension—Topiramate—obesity	4.72e-05	0.000292	CcSEcCtD
Naproxen—Nausea—Bupropion—obesity	4.71e-05	0.000291	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Topiramate—obesity	4.6e-05	0.000284	CcSEcCtD
Naproxen—Insomnia—Topiramate—obesity	4.56e-05	0.000282	CcSEcCtD
Naproxen—Paraesthesia—Topiramate—obesity	4.53e-05	0.00028	CcSEcCtD
Naproxen—Dyspnoea—Topiramate—obesity	4.5e-05	0.000278	CcSEcCtD
Naproxen—Somnolence—Topiramate—obesity	4.49e-05	0.000277	CcSEcCtD
Naproxen—Dyspepsia—Topiramate—obesity	4.44e-05	0.000275	CcSEcCtD
Naproxen—Decreased appetite—Topiramate—obesity	4.39e-05	0.000271	CcSEcCtD
Naproxen—Gastrointestinal disorder—Topiramate—obesity	4.36e-05	0.000269	CcSEcCtD
Naproxen—Fatigue—Topiramate—obesity	4.35e-05	0.000269	CcSEcCtD
Naproxen—Constipation—Topiramate—obesity	4.32e-05	0.000267	CcSEcCtD
Naproxen—Pain—Topiramate—obesity	4.32e-05	0.000267	CcSEcCtD
Naproxen—Feeling abnormal—Topiramate—obesity	4.16e-05	0.000257	CcSEcCtD
Naproxen—Gastrointestinal pain—Topiramate—obesity	4.13e-05	0.000255	CcSEcCtD
Naproxen—Urticaria—Topiramate—obesity	4.01e-05	0.000248	CcSEcCtD
Naproxen—Abdominal pain—Topiramate—obesity	3.99e-05	0.000247	CcSEcCtD
Naproxen—Body temperature increased—Topiramate—obesity	3.99e-05	0.000247	CcSEcCtD
Naproxen—Hypersensitivity—Topiramate—obesity	3.72e-05	0.00023	CcSEcCtD
Naproxen—Asthenia—Topiramate—obesity	3.62e-05	0.000224	CcSEcCtD
Naproxen—Pruritus—Topiramate—obesity	3.57e-05	0.000221	CcSEcCtD
Naproxen—Diarrhoea—Topiramate—obesity	3.45e-05	0.000214	CcSEcCtD
Naproxen—Dizziness—Topiramate—obesity	3.34e-05	0.000206	CcSEcCtD
Naproxen—Vomiting—Topiramate—obesity	3.21e-05	0.000198	CcSEcCtD
Naproxen—Rash—Topiramate—obesity	3.18e-05	0.000197	CcSEcCtD
Naproxen—Dermatitis—Topiramate—obesity	3.18e-05	0.000197	CcSEcCtD
Naproxen—Headache—Topiramate—obesity	3.16e-05	0.000196	CcSEcCtD
Naproxen—Nausea—Topiramate—obesity	3e-05	0.000185	CcSEcCtD
Naproxen—AKR1C3—Signaling Pathways—TGFB1—obesity	3.8e-06	4.2e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GOT1—obesity	3.8e-06	4.2e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GGT1—obesity	3.8e-06	4.2e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—SCARB1—obesity	3.79e-06	4.19e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—APOE—obesity	3.79e-06	4.18e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—LPL—obesity	3.78e-06	4.18e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—obesity	3.78e-06	4.18e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—GGT1—obesity	3.78e-06	4.17e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—GOT1—obesity	3.78e-06	4.17e-05	CbGpPWpGaD
Naproxen—AKR1C3—Disease—AKT1—obesity	3.77e-06	4.17e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—CAV1—obesity	3.75e-06	4.14e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—APOA1—obesity	3.74e-06	4.13e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—NCOA1—obesity	3.74e-06	4.13e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—obesity	3.74e-06	4.13e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PRKAR2B—obesity	3.73e-06	4.12e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—NCOA1—obesity	3.72e-06	4.11e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—DCN—obesity	3.7e-06	4.09e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—ALB—obesity	3.69e-06	4.08e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—GPX1—obesity	3.69e-06	4.08e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—STK11—obesity	3.69e-06	4.07e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CYP19A1—obesity	3.69e-06	4.07e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—SREBF1—obesity	3.68e-06	4.07e-05	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—PIK3R1—obesity	3.67e-06	4.05e-05	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—NOS3—obesity	3.67e-06	4.05e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—STK11—obesity	3.67e-06	4.05e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—CYP19A1—obesity	3.67e-06	4.05e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—obesity	3.64e-06	4.02e-05	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—PIK3CB—obesity	3.63e-06	4.01e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—PIK3CG—obesity	3.6e-06	3.98e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CPT1A—obesity	3.6e-06	3.98e-05	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—PTGS2—obesity	3.6e-06	3.97e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—CD36—obesity	3.59e-06	3.97e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GOT2—obesity	3.58e-06	3.96e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—obesity	3.53e-06	3.9e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—NAMPT—obesity	3.53e-06	3.9e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—BAD—obesity	3.53e-06	3.9e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—obesity	3.51e-06	3.88e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—LIPC—obesity	3.51e-06	3.87e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GCK—obesity	3.51e-06	3.87e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—FASN—obesity	3.5e-06	3.87e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—BCHE—obesity	3.49e-06	3.86e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—APOC3—obesity	3.49e-06	3.85e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—PPARG—obesity	3.48e-06	3.84e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—POMC—obesity	3.46e-06	3.82e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—POMC—obesity	3.43e-06	3.79e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—COMT—obesity	3.43e-06	3.79e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—INS—obesity	3.41e-06	3.77e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—COMT—obesity	3.41e-06	3.77e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—MTHFR—obesity	3.41e-06	3.76e-05	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—PIK3CB—obesity	3.39e-06	3.74e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CETP—obesity	3.38e-06	3.74e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GNB3—obesity	3.38e-06	3.73e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PPARGC1A—obesity	3.38e-06	3.73e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—IRS1—obesity	3.38e-06	3.73e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CYP2E1—obesity	3.37e-06	3.72e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—HMOX1—obesity	3.37e-06	3.72e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—GNB3—obesity	3.36e-06	3.71e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—PPARGC1A—obesity	3.36e-06	3.71e-05	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—PTGS2—obesity	3.36e-06	3.71e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—SDC1—obesity	3.35e-06	3.7e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—HMOX1—obesity	3.35e-06	3.7e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—PPARA—obesity	3.34e-06	3.69e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—NQO1—obesity	3.33e-06	3.68e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—AKR1C3—obesity	3.29e-06	3.64e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GNAS—obesity	3.29e-06	3.64e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—GNAS—obesity	3.27e-06	3.62e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—obesity	3.26e-06	3.6e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—SCARB1—obesity	3.24e-06	3.58e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—AGT—obesity	3.24e-06	3.57e-05	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—PIK3CA—obesity	3.23e-06	3.57e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—INS—obesity	3.23e-06	3.57e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—obesity	3.23e-06	3.57e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—APOB—obesity	3.22e-06	3.56e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—APOB—obesity	3.21e-06	3.54e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—obesity	3.2e-06	3.53e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GCG—obesity	3.19e-06	3.53e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—SLC2A4—obesity	3.19e-06	3.53e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—APOE—obesity	3.17e-06	3.5e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—PIK3CD—obesity	3.17e-06	3.5e-05	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—AKT1—obesity	3.16e-06	3.49e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—ALB—obesity	3.16e-06	3.49e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CYCS—obesity	3.15e-06	3.48e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—SREBF1—obesity	3.15e-06	3.48e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—CAV1—obesity	3.14e-06	3.47e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—APOA1—obesity	3.13e-06	3.46e-05	CbGpPWpGaD
Naproxen—ALB—Hemostasis—TGFB1—obesity	3.13e-06	3.46e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—ALB—obesity	3.13e-06	3.46e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—AKT2—obesity	3.13e-06	3.45e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GGT1—obesity	3.09e-06	3.41e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GOT1—obesity	3.09e-06	3.41e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—LPL—obesity	3.08e-06	3.4e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GOT2—obesity	3.06e-06	3.38e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—LPL—obesity	3.06e-06	3.38e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—NCOA1—obesity	3.05e-06	3.36e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—obesity	3.02e-06	3.33e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—PIK3CD—obesity	3e-06	3.32e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GPX1—obesity	3e-06	3.32e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—STK11—obesity	3e-06	3.32e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CYP19A1—obesity	3e-06	3.32e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	3e-06	3.32e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—FASN—obesity	3e-06	3.31e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—NOS3—obesity	2.99e-06	3.31e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—PIK3R1—obesity	2.99e-06	3.31e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—GPX1—obesity	2.99e-06	3.3e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—BCHE—obesity	2.98e-06	3.29e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—SERPINE1—obesity	2.97e-06	3.28e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CD36—obesity	2.92e-06	3.23e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—CD36—obesity	2.91e-06	3.21e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—TYK2—obesity	2.89e-06	3.19e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CYP2E1—obesity	2.88e-06	3.18e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—RHOA—obesity	2.87e-06	3.17e-05	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—IL6—obesity	2.86e-06	3.16e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—PIK3CG—obesity	2.86e-06	3.16e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—NQO1—obesity	2.85e-06	3.14e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—PIK3R1—obesity	2.84e-06	3.13e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—NOS3—obesity	2.84e-06	3.13e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—COMT—obesity	2.79e-06	3.08e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—obesity	2.79e-06	3.08e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—MTHFR—obesity	2.77e-06	3.06e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—PIK3CB—obesity	2.76e-06	3.05e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—PPARG—obesity	2.76e-06	3.05e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—obesity	2.76e-06	3.05e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—MTHFR—obesity	2.76e-06	3.04e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PPARGC1A—obesity	2.75e-06	3.04e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GNB3—obesity	2.75e-06	3.04e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—HMOX1—obesity	2.74e-06	3.03e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—PTGS2—obesity	2.74e-06	3.02e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GCG—obesity	2.73e-06	3.01e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—SLC2A4—obesity	2.73e-06	3.01e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—POMC—obesity	2.72e-06	3.01e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PPARA—obesity	2.72e-06	3e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—INS—obesity	2.71e-06	2.99e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—PPARA—obesity	2.7e-06	2.99e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CYCS—obesity	2.69e-06	2.97e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GNAS—obesity	2.68e-06	2.96e-05	CbGpPWpGaD
Naproxen—ALB—Hemostasis—PIK3CA—obesity	2.67e-06	2.95e-05	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—AKT1—obesity	2.64e-06	2.92e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GGT1—obesity	2.64e-06	2.92e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GOT1—obesity	2.64e-06	2.92e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—AGT—obesity	2.63e-06	2.91e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—APOB—obesity	2.62e-06	2.9e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—MTOR—obesity	2.62e-06	2.89e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—PIK3CB—obesity	2.62e-06	2.89e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—AGT—obesity	2.62e-06	2.89e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—NCOA1—obesity	2.6e-06	2.87e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—APOE—obesity	2.58e-06	2.85e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—APOE—obesity	2.57e-06	2.83e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—STK11—obesity	2.56e-06	2.83e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CYP19A1—obesity	2.56e-06	2.83e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CAV1—obesity	2.56e-06	2.82e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—APOA1—obesity	2.55e-06	2.82e-05	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—PIK3CA—obesity	2.54e-06	2.81e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—CAV1—obesity	2.54e-06	2.81e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—APOA1—obesity	2.54e-06	2.8e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—PIK3CD—obesity	2.52e-06	2.78e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—LPL—obesity	2.5e-06	2.77e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—ALB—obesity	2.48e-06	2.74e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GPX1—obesity	2.44e-06	2.7e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.44e-06	2.7e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.43e-06	2.68e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—COMT—obesity	2.38e-06	2.63e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CD36—obesity	2.38e-06	2.63e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—NOS3—obesity	2.38e-06	2.62e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—PIK3R1—obesity	2.38e-06	2.62e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PPARGC1A—obesity	2.35e-06	2.6e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GNB3—obesity	2.35e-06	2.6e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—HMOX1—obesity	2.34e-06	2.59e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PIK3CG—obesity	2.33e-06	2.57e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—PIK3CG—obesity	2.32e-06	2.56e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GNAS—obesity	2.29e-06	2.53e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—MTHFR—obesity	2.26e-06	2.49e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PPARG—obesity	2.25e-06	2.48e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—APOB—obesity	2.24e-06	2.48e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—PPARG—obesity	2.23e-06	2.47e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—POMC—obesity	2.22e-06	2.45e-05	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—PIK3CA—obesity	2.21e-06	2.44e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PPARA—obesity	2.21e-06	2.44e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—INS—obesity	2.2e-06	2.43e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—POMC—obesity	2.2e-06	2.43e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—PIK3CB—obesity	2.19e-06	2.42e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—INS—obesity	2.19e-06	2.42e-05	CbGpPWpGaD
Naproxen—ALB—Hemostasis—AKT1—obesity	2.18e-06	2.41e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—AGT—obesity	2.14e-06	2.37e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—LPL—obesity	2.14e-06	2.36e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—APOE—obesity	2.1e-06	2.32e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GPX1—obesity	2.09e-06	2.31e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CAV1—obesity	2.08e-06	2.3e-05	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—AKT1—obesity	2.08e-06	2.29e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—APOA1—obesity	2.08e-06	2.29e-05	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—PIK3CA—obesity	2.07e-06	2.28e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PIK3CD—obesity	2.05e-06	2.26e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—PIK3CD—obesity	2.04e-06	2.25e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CD36—obesity	2.03e-06	2.25e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—STAT3—obesity	2.02e-06	2.23e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—ALB—obesity	2.02e-06	2.23e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.99e-06	2.2e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PIK3R1—obesity	1.93e-06	2.13e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—NOS3—obesity	1.93e-06	2.13e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—MTHFR—obesity	1.93e-06	2.13e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—PIK3R1—obesity	1.92e-06	2.12e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—NOS3—obesity	1.92e-06	2.12e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PIK3CG—obesity	1.89e-06	2.09e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PPARA—obesity	1.89e-06	2.09e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—MYC—obesity	1.88e-06	2.08e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—TGFB1—obesity	1.88e-06	2.07e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—AGT—obesity	1.83e-06	2.02e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PPARG—obesity	1.83e-06	2.02e-05	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—AKT1—obesity	1.81e-06	2e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—POMC—obesity	1.8e-06	1.99e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—APOE—obesity	1.79e-06	1.98e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—INS—obesity	1.79e-06	1.98e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PIK3CB—obesity	1.78e-06	1.97e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CAV1—obesity	1.78e-06	1.96e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—PIK3CB—obesity	1.77e-06	1.96e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—APOA1—obesity	1.77e-06	1.96e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PTGS2—obesity	1.77e-06	1.95e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—PTGS2—obesity	1.76e-06	1.94e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.7e-06	1.88e-05	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—AKT1—obesity	1.69e-06	1.86e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—PIK3CA—obesity	1.68e-06	1.86e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PIK3CD—obesity	1.67e-06	1.84e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—ALB—obesity	1.64e-06	1.82e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PIK3CG—obesity	1.62e-06	1.79e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—PIK3CA—obesity	1.6e-06	1.76e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—NOS3—obesity	1.57e-06	1.74e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PIK3R1—obesity	1.57e-06	1.74e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PPARG—obesity	1.56e-06	1.73e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—POMC—obesity	1.54e-06	1.7e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—INS—obesity	1.53e-06	1.69e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PIK3CB—obesity	1.45e-06	1.6e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PTGS2—obesity	1.44e-06	1.59e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PIK3CD—obesity	1.42e-06	1.57e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—IL6—obesity	1.41e-06	1.56e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ALB—obesity	1.41e-06	1.55e-05	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—AKT1—obesity	1.38e-06	1.52e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PIK3R1—obesity	1.34e-06	1.48e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—NOS3—obesity	1.34e-06	1.48e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—PIK3CA—obesity	1.34e-06	1.48e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—AKT1—obesity	1.3e-06	1.44e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PIK3CB—obesity	1.24e-06	1.37e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PTGS2—obesity	1.23e-06	1.36e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—AKT1—obesity	1.09e-06	1.21e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PIK3CA—obesity	1.09e-06	1.2e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—PIK3CA—obesity	1.08e-06	1.19e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—AKT1—obesity	8.88e-07	9.81e-06	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PIK3CA—obesity	8.85e-07	9.78e-06	CbGpPWpGaD
Naproxen—ALB—Metabolism—AKT1—obesity	8.83e-07	9.76e-06	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PIK3CA—obesity	7.56e-07	8.36e-06	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—AKT1—obesity	7.23e-07	7.99e-06	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—AKT1—obesity	6.18e-07	6.83e-06	CbGpPWpGaD
